The upregulation of FOXL2 (downregulated upon RBPMS knockout) has been found to suppress cervical cancer cell proliferation and facilitate the apoptosis of these cells [69,70]; thus, it could be important to study the role of FOXL2 in ovarian cancer. Here, RBPMS is linked to cervical carcinoma.